Clinical Outcomes of S-1 Monotherapy and Modified FOLFIRINOX Therapy after Gemcitabine plus Nab-paclitaxel Therapy in Unresectable Pancreatic Cancer.
Hino K, Nishina T, Numata Y, Asagi A, Inoue T, Yoshimatsu M, Sakaguchi C, Nakasya A, Nishide N, Kajiwara T, Terao T, Nadano S, Marui K, Okujima Y, Kokubu M, Imamura Y, Kanemitsu K, Koizumi M, Kumagi T, Hiasa Y, Hyodo I.
Hino K, et al. Among authors: okujima y.
Intern Med. 2022;61(15):2255-2261. doi: 10.2169/internalmedicine.8736-21. Epub 2022 Aug 1.
Intern Med. 2022.
PMID: 35908959
Free PMC article.